Trademarkia Logo

Australia

AU$
RIVZEPRI
Protected: Registered/protected

Last updated on 1 Dec 2022

Owner Info

FibroGen, Inc.

409 Illinois Street

San Francisco CA 94158, UNITED STATES OF AMERICA

Serial Number

2300427 filed on 12 Aug 2022

Correspondent

Harold Milstein Sheppard Mullin Richter & Hampton LLP

1540 El Camino Real, Suite 120,

Menlo Park CA 94025,

UNITED STATES OF AMERICA

RIVZEPRI

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of chronic fibrotic and proliferative disorders; pharmaceutical preparations for the treatment of cancer Read More

Mark Details


Serial Number

2300427

Registered On

12 Aug 2022

Renewal On

12 Aug 2032

Mark Type

WORD

Priority Claim (Convention Details)


Date

18 Feb 2022

Mark Type

US

Legal History


Show more

Status DateAction Taken
1st Dec 2022International Registration in Australia Protected correspondence sent
30th Nov 2022IP Right Registration Published
30th Nov 2022Status change to Registered/Protected
24th Sept 2022Application Accepted correspondence sent
23rd Sept 2022IP Right has been Examined
23rd Sept 2022IP Right Acceptance Published
23rd Sept 2022Status change to Accepted
20th Sept 2022Awaiting examination
20th Sept 2022Examination expedited
15th Sept 2022IP Right Filed Published